102 related articles for article (PubMed ID: 1490379)
1. Lymphocyte activation and the family of NF-kappa B transcription factor complexes.
Bours V; Franzoso G; Brown K; Park S; Azarenko V; Tomita-Yamaguchi M; Kelly K; Siebenlist U
Curr Top Microbiol Immunol; 1992; 182():411-20. PubMed ID: 1490379
[No Abstract] [Full Text] [Related]
2. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.
Fujita T; Nolan GP; Ghosh S; Baltimore D
Genes Dev; 1992 May; 6(5):775-87. PubMed ID: 1577272
[TBL] [Abstract][Full Text] [Related]
3. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
4. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
5. Proposed NF-kappa B/I kappa B family nomenclature.
Nabel GJ; Verma IM
Genes Dev; 1993 Nov; 7(11):2063. PubMed ID: 8224837
[No Abstract] [Full Text] [Related]
6. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
7. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.
Köntgen F; Grumont RJ; Strasser A; Metcalf D; Li R; Tarlinton D; Gerondakis S
Genes Dev; 1995 Aug; 9(16):1965-77. PubMed ID: 7649478
[TBL] [Abstract][Full Text] [Related]
8. Rel/NF-kappa B and I kappa B proteins: an overview.
May MJ; Ghosh S
Semin Cancer Biol; 1997 Apr; 8(2):63-73. PubMed ID: 9299584
[TBL] [Abstract][Full Text] [Related]
9. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen.
Weih F; Carrasco D; Bravo R
Oncogene; 1994 Nov; 9(11):3289-97. PubMed ID: 7936653
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.
Mercurio F; Didonato J; Rosette C; Karin M
DNA Cell Biol; 1992 Sep; 11(7):523-37. PubMed ID: 1388725
[TBL] [Abstract][Full Text] [Related]
11. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
[TBL] [Abstract][Full Text] [Related]
12. The nfkb1 promoter is controlled by proteins of the Ets family.
Lambert PF; Ludford-Menting MJ; Deacon NJ; Kola I; Doherty RR
Mol Biol Cell; 1997 Feb; 8(2):313-23. PubMed ID: 9190210
[TBL] [Abstract][Full Text] [Related]
13. Autoregulation of I kappa B alpha activity.
Chiao PJ; Miyamoto S; Verma IM
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):28-32. PubMed ID: 8278379
[TBL] [Abstract][Full Text] [Related]
14. Rel/NF-kappa B and I kappa B factors in oncogenesis.
Luque I; Gélinas C
Semin Cancer Biol; 1997 Apr; 8(2):103-11. PubMed ID: 9299588
[TBL] [Abstract][Full Text] [Related]
15. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.
Neri A; Chang CC; Lombardi L; Salina M; Corradini P; Maiolo AT; Chaganti RS; Dalla-Favera R
Cell; 1991 Dec; 67(6):1075-87. PubMed ID: 1760839
[TBL] [Abstract][Full Text] [Related]
16. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
Mercurio F; DiDonato JA; Rosette C; Karin M
Genes Dev; 1993 Apr; 7(4):705-18. PubMed ID: 8458581
[TBL] [Abstract][Full Text] [Related]
17. The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.
Neri A; Fracchiolla NS; Migliazza A; Trecca D; Lombardi L
Leuk Lymphoma; 1996 Sep; 23(1-2):43-8. PubMed ID: 9021684
[TBL] [Abstract][Full Text] [Related]
18. Rel/NF-kappa B transcription factors and I kappa B inhibitors: evolution from a unique common ancestor.
Huguet C; Crepieux P; Laudet V
Oncogene; 1997 Dec; 15(24):2965-74. PubMed ID: 9416840
[TBL] [Abstract][Full Text] [Related]
19. BCL-6 negatively regulates expression of the NF-kappaB1 p105/p50 subunit.
Li Z; Wang X; Yu RY; Ding BB; Yu JJ; Dai XM; Naganuma A; Stanley ER; Ye BH
J Immunol; 2005 Jan; 174(1):205-14. PubMed ID: 15611242
[TBL] [Abstract][Full Text] [Related]
20. A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.
Kamens J; Brent R
New Biol; 1991 Oct; 3(10):1005-13. PubMed ID: 1768648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
